Effectiveness of OHD E-Waste Project Confirmed
Epichem Confirms Effectiveness of OHD E-Waste Project to convert mixed e-waste via oxidative dissolution into small organic molecules
News
Drugs for Neglected Diseases Contract Renewal
Epichem is excited to announce that our partnership with the Drugs for Neglected Diseases Initiative to develop life-saving medicines for people with neglected diseases around the world will continue in 2022.
Reaching a Global Audience for OHD
Reaching a global audience via CNBC Asia TV was an exciting opportunity for Epichem.
Talking Innovation
At Epichem we love to talk innovation. Thanks Eve Chye at “If Innovation Could Talk” for great questions for our CEO, Colin La Galia, about turning ideas into action.
Milestone Reached for Laboratory Expansion
Epichem is pleased to announce that the final repayment has been made on our major laboratory expansion in Technology Park, Western Australia.
OHD Benchtop Flow Reactor Launch
The innovative OHD benchtop flow reactor is now operating. Minister for Innovation, Hon. Don Punch MLA, cut the ribbon recently with Epichem CEO, Colin La Galia, while Dr Soeren Bock demonstrated the conversion of coal and solid e-waste products into-high value chemicals.
Export Award Celebrates Resilience
Hon Steve Irons MP, recently dropped by to present Epichem CEO Colin La Galia and the team an Australian Export & Investment Award. Epichem is one of only 8 companies recognised for incredible resilience in the the face of major COVID disruptions in 2020.
Epichem & Sanoosa – Teaming up Against Tumors
Epichem is proud to announce a new partnership with Sanoosa, a computational drug discovery company, to develop a novel compound series active and selective against cancers caused by RAS mutations.
Developing Treatments for Retinitis Pigmentosa
Epichem is pleased to partner with another Perth WA based research group, PYC Therapeutics, on developing a new treatment for Retinitis Pigmentosa a devastating genetic disorder which causes loss of vision.